Search results
15 kwi 2024 · CLINICAL APPROACH. The clinical approach to S. aureus bacteremia consists of careful history and physical examination, infectious disease consultation, and diagnostic evaluation including echocardiography and additional imaging as needed. History and physical examination.
- Khandheria Bk, Seward Jb, Tajik Aj. Transesophageal Echocardiography. Mayo Clin Proc 1994; 69:856
Twenty-one percent were methicillin-resistant Staphylococcus...
- Medline
Prospective Validation of PREDICT and Its Impact on the...
- Contributor Disclosures
{{configCtrl2.info.metaDescription}}
- 18F
Calculated numbers needed to treat for receipt of...
- Baltimore
Staphylococcus aureus was the predominant pathogen (65%) and...
- Arrest
FINDINGS Between Dec 10, 2012, and Oct 25, 2016, 758...
- Elinor L Baron, MD, DTMH
Clinical approach to Staphylococcus aureus bacteremia in...
- Sullenberger Al, Avedissian Ls, Kent Sm. Importance of Transesophageal Echocardiography in The Evaluation of Staphylococcus Aureus Bacteremia. J Heart Valve Dis 2005; 14:23
Echocardiography is dispensable in uncomplicated...
- Khandheria Bk, Seward Jb, Tajik Aj. Transesophageal Echocardiography. Mayo Clin Proc 1994; 69:856
10 lis 2023 · In a recent randomized controlled trial (RCT), the use of rmPCR compared with standard blood culture processing was associated with shorter time to narrow-spectrum beta-lactam therapy in patients with methicillin-susceptible S. aureus (MSSA), especially when coupled with an antibiotic stewardship intervention in which the primary service was ...
31 paź 2023 · Staphylococcus aureus bloodstream infection (bacteremia) is traditionally treated with at least 2 weeks of intravenous (IV) antibiotics in adults, 3–7 days in children, and often longer for those with complicated disease. The current practice of treating S. aureus bacteremia (SAB) with prolonged IV antibiotics (rather than oral antibiotics) is based on historical observational research and ...
17 lip 2023 · Treatment of S. aureus infections depends largely on the type of infection as well as the presence or absence of drug resistant strains. [6] When antimicrobial therapy is needed, the duration and mode of therapy are largely dependent on the infection type as well as other factors. [6]
3 maj 2023 · Staphylococcus aureus is a major cause of nosocomial and community-acquired infections and contributes to significant increase in morbidity and mortality especially when associated with medical devices and in biofilm form.
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections.
Treatment Outcome. Substances. Anti-Bacterial Agents. Staphylococcus aureus bacteremia (SAB) is still a daily challenge for clinicians. Despite all efforts, the associated mortality and morbidity has not significantly improved in the last 20 years.
